Results 71 to 80 of about 1,213,338 (213)

Combination of pemetrexed with bevacizumab for non-small-cell lung cancer: a meta-analysis study

Journal of Cardiothoracic Surgery
Background Combining pemetrexed with bevacizumab may have some potential in improving the efficacy in patients with non-small-cell lung cancer (NSCLC), and this meta-analysis aims to explore the impact of pemetrexed addition to bevacizumab on treatment ...
Wei Fang, Xingqiao Peng, Qun Zhou
doaj   +1 more source

Long-term outcomes and prognostic factors after surgery alone for brain arteriovenous malformation

Brain Circulation
OBJECTIVES: There is a paucity of data regarding the long-term hemorrhage/progression outcomes of brain arteriovenous malformation (BAVM). The purpose of this study was to examine the outcomes of surgical treatment alone over a long follow-up period ...
Zhao-Ying Zhu, Wei Zhang, Li-Chuan Gao, Gui-Jun Zhang, Jing Chen   +4 more
doaj   +1 more source

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial. [PDF]

, 2017
Tumor-treating fields (TTFields) is an antimitotic treatment modality that interferes with glioblastoma cell division and organelle assembly by delivering low-intensity alternating electric fields to the tumor.
Ahluwalia, M.S., Brem, S., Burna, J., Di Meco, F., Fink, K., Hegi, M.E., Hirte, H., Hottinger, A.F., Idbaih, A., Kanner, A., Kim, C.Y., Kirson, E.D., Lavy-Shahaf, G., Lhermitte, B., Lieberman, F., Nicholas, G., Paek, S.H., Palti, Y., Ram, Z., Read, W., Steinberg, D.M., Stragliotto, G., Stupp, R., Taillibert, S., Toms, S., Tran, D.D., Weinberg, U., Weller, M., Zhu, J.J.   +28 more
core   +4 more sources

Prognostic significance of circulating tumor DNA detection and quantification in cervical cancer: a systematic review and meta-analysis

Frontiers in Oncology
BackgroundCirculating tumor DNA (ctDNA) is an emerging biomarker in cervical cancer, with elevated levels typically indicating a higher tumor burden. However, its prognostic value in cervical cancer patients remains debated.
Xiumin Zhao, Shufu Hou, Ruiqi Hao, Yelei Zang, Dandan Song   +4 more
doaj   +1 more source

Activity of eribulin mesylate in brain metastasis from breast cancer. a stone in a pond? [PDF]

, 2018
Background: Brain metastases develop in approximately 10-25% of patients with metastatic breast cancer (MBC) and are associated with a very poor prognosis.
Catania, G., Cognetti, F., Fabi, A., Gasparro, S., Malaguti, P., Vidiri, A.   +5 more
core   +1 more source

Perioperative Chemotherapy in Gastroesophageal Cancer. A Retrospective Monocenter Evaluation of 42 Cases

, 2015
Background: Perioperative chemotherapy increases the overall and progression-free survival of patients suffering from resectable adenocarcinomas of the lower esophagus, gastroesophageal junction and stomach (GEC).
Berdel, W.E. (Wolfgang), Brehler, A. (Ann-Christin), Hartmann, W. (Wolfgang), Kerkhoff, A. (Andrea), Keßler, T. (Torsten), Lenze, F. (Frank), Palmes, D.M. (Daniel), Schliemann, C. (Christoph), Senninger, N. (Norbert), Ullerich, H. (Hansjörg), Wiebe, S. (Stefanie)   +10 more
core   +2 more sources

The Association between Vitamin D Receptor Expression and Prolonged Overall Survival in Breast Cancer. [PDF]

, 2012
Summary In this study, we analyzed vitamin D receptor (VDR) expression and survival in a breast cancer patient cohort of 82 breast cancer patients. Immunohistochemical analysis was possible in 91.5% of the patients (75/82). Staining was evaluated using
Berger U, Berger U, Boecker W, Conde I, Eisman JA, Frampton RJ, Freake HC, Gombart AF, Jeschke U, Mason BH, Mylonas I, Remmele W, Ulmann A, Zinser GM   +13 more
core   +2 more sources

What does the post radiotherapy prostate specific antigen (PSA) nadir tell us about progression-free-survival in patients with localized cancer [PDF]

, 2001
Kassandra Doyle, Mack Roach, Vivian Weinberg, Patrick W. McLaughlin, Howard M. Sandler   +4 more
openalex   +1 more source

Multi-institutional validation of a radiomics signature for identification of postoperative progression of soft tissue sarcoma

Cancer Imaging
Background To develop a magnetic resonance imaging (MRI)-based radiomics signature for evaluating the risk of soft tissue sarcoma (STS) disease progression.
Yuan Yu, Hongwei Guo, Meng Zhang, Feng Hou, Shifeng Yang, Chencui Huang, Lisha Duan, Hexiang Wang   +7 more
doaj   +1 more source

Correlation between progression free survival and response rate in patients with metastatic colorectal carcinoma [PDF]

, 2001
Christophe Louvet, Aimery de Gramont, Christophe Tournigand, Pascal Artru, Frédérique Maindrault‐Gœbel, M Krulik   +5 more
openalex   +1 more source